A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
for Chronic Obstructive Pulmonary Disease
63 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 40 - 90
Code: NCT05878769·Phase 3·Recruiting·Listed May 2023